You are here

Article Text

Article menu
Download PDFPDF
Commentary
Do we need another emergency department procedural sedation agent?
  1. Gene Yong-Kwang Ong1,2
  1. 1 Duke-NUS Medical School, Singapore
  2. 2 Department of Emergency Medicine, KK Women’s and Children’s Hospital, Singapore
  1. Correspondence to Dr Gene Yong-Kwang Ong; geneong{at}yahoo.com

https://doi.org/10.1136/emermed-2024-214255

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Currently, various sedative agents are widely used and researched for procedural sedation in EDs. Ensuring safe and effective sedation during painful procedures necessitates appropriate patient selection, a thorough understanding of drug safety profiles and awareness of potential patient–drug interactions. Remimazolam, a sedative previously evaluated in intensive care and anaesthesiology units, has seen more extensive exploration in ambulatory procedural sedation, particularly for endoscopic and dental procedures, than in ED settings.1–6

    In their EMJ paper, van der Have et al present a research letter detailing their dual-centre experience with remimazolam for procedural sedation in EDs, primarily for …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles